• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAXTER HEALTHCARE CORPORATION CLEARLINK/CONTINU-FLO; SET, ADMINISTRATION, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAXTER HEALTHCARE CORPORATION CLEARLINK/CONTINU-FLO; SET, ADMINISTRATION, INTRAVASCULAR Back to Search Results
Model Number 2R8537
Medical Device Problem Code Filling Problem (1233)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
B3/d10 therapy date: the exact date of event is unknown; however, this was reported to have occurred in the "past three days" prior to february 24, 2026.D4: unique identifier (udi) #: the lot # is unknown; therefore, the udi contains only the primary di number.The device was not returned and the lot number is unknown; therefore, a device analysis could not be completed.Should additional relevant information become available, a supplemental report will be submitted.
 
Event or Problem Description
It was reported that a clearlink continu-flo solution set was being used during an underinfusion of flagyl.This occurred during use with a baxter infusion pump.The underinfusion was noted to be greater than 10%.Clinicians returned to the bedside at the infusion complete screen/alarm and found that the medication had not infused, despite the pump having transmitted intake volume data consistent with a completed infusion.There was no report of patient injury or medical intervention associated with this event.No additional information is available.
 
Additional Manufacturer Narrative
This report is intendended to correct investigation conclusions (h6) coding.The orginal investigation conclusion was submitted as d16, but the correct investigation conclusion was d15.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CLEARLINK/CONTINU-FLO
Common Device Name
SET, ADMINISTRATION, INTRAVASCULAR
Manufacturer (Section D)
BAXTER HEALTHCARE CORPORATION
deerfield IL
Manufacturer (Section G)
BAXTER HEALTHCARE - CARTAGO
parque industrial de cartago
apartado no. 1-7052
cartago
CS  
Manufacturer Contact
25212 w. illinois route 120
round lake, IL 60073
2242705355
MDR Report Key24690328
Report Number1416980-2026-01065
Device Sequence Number15963088
Product Code FPA
UDI-Device Identifier00085412565743
UDI-Public(01)00085412565743
Combination Product (Y/N)N
Initial Reporter StateMO
Initial Reporter CountryUS
PMA/510(K) Number
K180739
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 06/04/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model Number2R8537
Device Catalogue Number2R8537
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 02/24/2026
Supplement Date Received by Manufacturer05/13/2026
Initial Report FDA Received Date03/25/2026
Supplement Report FDA Received Date06/04/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
FLAGYL; SPECTRUM IQ INFUSION PUMP
Patient SexUnknown
-
-